>AT3G28380.1 |  PGP17 (P-GLYCOPROTEIN 17) ATP binding / ATPase/ ATPase coupled to transmembrane movement of substances / nucleoside-triphosphatase/ nucleotide binding 
MGKEDEKESGRDKMKSFGSIRSIFMHADGVDWILMALGLIGAVGDGFITPVVVFIFNTLL 
NNLGTSSSNNKTFMQTISKNVVALLYVACGSWVICFLEGYCWTRTGERQAARMREKYLRA 
VLRQDVGYFDLHVTSTSDVITSISSDSLVIQDFLSEKLPNFLMNASAFVASYIVSFILMW 
RLTIVGFPFIILLLVPGLMYGRALVSISRKIHEQYNEAGSIAEQAISSVRTVYAFGSENK 
MIGKFSTALRGSVKLGLRQGLAKGITIGSNGVTHAIWAFLTWYGSRLVMNHGSKGGTVFV 
VISCITYGGVSLGQSLSNLKYFSEAFVAWERILEVIKRVPDIDSNKKEGQILERMKGEVE 
FNHVKFTYLSRPETTIFDDLCLKIPAGKTVALVGGSGSGKSTVISLLQRFYDPIAGEILI 
DGVSIDKLQVNWLRSQMGLVSQEPVLFATSITENILFGKEDASLDEVVEAAKASNAHTFI 
SQFPLGYKTQVGERGVQMSGGQKQRIAIARAIIKSPKILLLDEATSALDSESERVVQESL 
DNASIGRTTIVIAHRLSTIRNADVICVIHNGQIVETGSHEELLKRIDGQYTSLVSLQQME 
NEESNVNINVSVTKDQVMSLSKDFKYSQHNSIGSTSSSIVTNVSDLIPNDNQPLVPSFTR 
LMVMNRPEWKHALYGCLSAALVGVLQPVSAYSAGSVISVFFLTSHDQIKEKTRIYVLLFV 
GLAIFSFLVNISQHYGFAYMGEYLTKRIREQMLSKILTFEVNWFDIDDNSSGAICSRLAK 
DANVVRSMVGDRMSLLVQTISAVIIACIIGLVIAWRLAIVMISVQPLIVVCFYTQRVLLK 
SLSEKASKAQDESSKLAAEAVSNIRTITAFSSQERIIKLLKKVQEGPRRESVHRSWLAGI 
VLGTSRSLITCTSALNFWYGGRLIADGKIVSKAFFEIFLIFVTTGRVIADAGTMTTDLAR 
GLDAVGSVFAVLDRCTTIEPKNPDGYVAEKIKGQITFLNVDFAYPTRPDVVIFENFSIEI 
DEGKSTAIVGTSGSGKSTIIGLIERFYDPLKGTVKIDGRDIRSYHLRSLRKYISLVSQEP 
MLFAGTIRENIMYGGTSDKIDESEIIEAAKAANAHDFITSLSNGYDTNCGDKGVQLSGGQ 
KQRIAIARAVLKNPSVLLLDEATSALDSKSERVVQDALERVMVGRTSIMIAHRLSTIQNC 
DMIVVLGKGKIVESGTHSSLLEKGPTGTYFSLAGIQRTLC*
>AT3G44630.3 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRAFSLSLSHSPFLSLCLMDWLMIRFLLMGFRCVSS*
>AT3G44630.3 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRAFSLSLSHSPFLSLCLMDWLMIRFLLMGFRCVSS*
>AT3G44630.3 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRAFSLSLSHSPFLSLCLMDWLMIRFLLMGFRCVSS*
>AT3G44630.2 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRVFLARTTV*
>AT3G44630.2 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRVFLARTTV*
>AT3G44630.2 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRVFLARTTV*
>AT3G44630.1 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRVFLARTTV*
>AT3G44630.1 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRVFLARTTV*
>AT3G44630.1 |  disease resistance protein RPP1-WsB-like (TIR-NBS-LRR class) putative 
MGSAMSLSCSKRKATSQDVDSESCKRRKTCSTNDAENCIFIPDESSWSLCANRVITVAAV 
ALTNFRFQQDNQESNSSSLSLPSLATSVSRNWKHDVFPSFHGADVRRTFLSHIMESFRRK 
GIDTFIDNNIERSKSIGPELKEAIKGSKIAIVLLSRKYASSSWCLDELAEIMKCRQMVGQ 
IVMTIFYEVEPTDIKKQTGEFGKAFTKTCRGKPKEQVERWRKALEDVATIAGYHSHSWRN 
EADMIEKIATDVSNMLNSFTPSRDFDGLVGMRAHMDMLEQLLRLDLDEVRIIGIWGPPGI 
GKTTIARFLLNQVSDRFQLSAIMVNIKGCYPRPCFDEYSAQLQLQNQMLSQMINHKDIMI 
SHLGVAQERLRDKKVFLVLDEVDQLGQLDALAKETRWFGPGSRIIITTEDLGVLKAHGIN 
HVYKVEYPSNDEAFQIFCMNAFGQKQPHEGFDEIAWEVKALAGKLPLGLKVLGSALRGKS 
KPEWERTLPRLRTSLDGKIGGIIQFSYDALCDEDKYLFLYIACLFNGESTTKVKELLGKF 
LDVRQGLHVLAQKSLISFDEEISWKQIVQVLLLNKFSHVRHTKRNKSQIIRMHTLLEQFG 
RETSRKQFVHHRYTKHQLLVGERDICEVLDDDTTDNRRFIGINLDLYKNEEELNISEKAL 
ERIHDFQFVKINYVFTHQPERVQLALEDLIYHSPRIRSLKWFPYQNICLPSTFNPEFLVE 
LDMRCSKLRKLWEGTKQLRNLKWMDLSDSRDLKELPSSIEKLTSLQILDLRDCSSLVKLP 
PSINANNLQGLSLTNCSRVVKLPAIENVTNLHQLKLQNCSSLIELPLSIGTANNLWKLDI 
RGCSSLVKLPSSIGDMTNLKEFDLSNCSNLVELPSSIGNLQKLFMLRMRGCSKLETLPTN 
INLISLRILDLTDCSQLKSFPEISTHISELRLKGTAIKEVPLSITSWSRLAVYEMSYFES 
LKEFPHALDIITDLLLVSEDIQEVPPWVKRMSRLRALRLNNCNSLVSLPQLPDSLDYIYA 
DNCKSLERLDCCFNNPEIRLYFPKCFKLNQEARDLIMHTSTRKYAMLPSIQVPACFNHRA 
TSGDYLKIKLKESSLPTTLRFKACIMLVKVNEEMRDDEMWPSVLIAIRVKQNDLKVLCTA 
SIYPVLTEHIYTFELEVEEVTSTELVFEFTPFHKSNWKIGECGILQRETRSFCRSSSPDL 
PPESSRVFLARTTV*
>AT3G28345.1 |  ABC transporter family protein 
MGKEEEKESGRNKMNCFGSVRSIFMHADGVDWLLMGLGLIGAVGDGFTTPLVLLITSKLM 
NNIGGSSFNTDTFMQSISKNSVALLYVACGSWVVCFLEGYCWTRTGERQTARMREKYLRA 
VLRQDVGYFDLHVTSTSDVITSVSSDSFVIQDVLSEKLPNFLMSASTFVGSYIVGFILLW 
RLAIVGLPFIVLLVIPGLMYGRALISISRKIREEYNEAGFVAEQAISSVRTVYAFSGERK 
TISKFSTALQGSVKLGIKQGLAKGITIGSNGITFAMWGFMSWYGSRMVMYHGAQGGTVFA 
VAAAIAIGGVSLGGGLSNLKYFFEAASVGERIMEVINRVPKIDSDNPDGHKLEKIRGEVE 
FKNVKFVYPSRLETSIFDDFCLRVPSGKTVALVGGSGSGKSTVISLLQRFYDPLAGEILI 
DGVSIDKLQVKWLRSQMGLVSQEPALFATTIKENILFGKEDASMDDVVEAAKASNAHNFI 
SQLPNGYETQVGERGVQMSGGQKQRIAIARAIIKSPTILLLDEATSALDSESERVVQEAL 
ENASIGRTTILIAHRLSTIRNADVISVVKNGHIVETGSHDELMENIDGQYSTLVHLQQIE 
KQDINVSVKIGPISDPSKDIRNSSRVSTLSRSSSANSVTGPSTIKNLSEDNKPQLPSFKR 
LLAMNLPEWKQALYGCISATLFGAIQPAYAYSLGSMVSVYFLTSHDEIKEKTRIYALSFV 
GLAVLSFLINISQHYNFAYMGEYLTKRIRERMLSKVLTFEVGWFDRDENSSGAICSRLAK 
DANVVRSLVGDRMALVVQTVSAVTIAFTMGLVIAWRLALVMIAVQPVIIVCFYTRRVLLK 
SMSKKAIKAQDESSKLAAEAVSNVRTITAFSSQERIMKMLEKAQESPRRESIRQSWFAGF 
GLAMSQSLTSCTWALDFWYGGRLIQDGYITAKALFETFMILVSTGRVIADAGSMTTDLAK 
GSDAVGSVFAVLDRYTSIDPEDPDGYETERITGQVEFLDVDFSYPTRPDVIIFKNFSIKI 
EEGKSTAIVGPSGSGKSTIIGLIERFYDPLKGIVKIDGRDIRSYHLRSLRRHIALVSQEP 
TLFAGTIRENIIYGGVSDKIDEAEIIEAAKAANAHDFITSLTEGYDTYCGDRGVQLSGGQ 
KQRIAIARAVLKNPSVLLLDEATSALDSQSERVVQDALERVMVGRTSVVIAHRLSTIQNC 
DAIAVLDKGKLVERGTHSSLLSKGPTGIYFSLVSLQTTSG*